Biopolymer nanoparticle production for controlled release of biopharmaceuticals

References

• Agnihotri SA, Mallikarjuna NN, Aminabhavi TM. 2004. Recent advances on chitosan-based micro- and nanoparticles in drug delivery. J Control Release 100: 5–28
   PubMed Web of Science ®Google Scholar
• Ahmad Z, Sharma S, Khuller GK. 2007. Chemotherapeutic evaluation of alginate nanoparticle-encapsulated azole antifungal and antitubercular drugs against murine tuberculosis. Nanomedicine 3: 239–243
   PubMed Web of Science ®Google Scholar
• Akagi T, Kaneko T, Kida T, Akashi M. 2005. Preparation and characterization of biodegradable nanoparticles based on poly(γ-glutamic acid) with l-phenylalanine as a protein carrier. J Control Release 108: 226–236
   PubMed Web of Science ®Google Scholar
• Akagi T, Kaneko T, Kida T, Akashi M. 2006. Multifunctional conjugation of proteins on/into bio-nanoparticles prepared by amphiphilic poly(γ-glutamic acid). J Biomater Sci Polym Ed 17: 875–892
   PubMed Web of Science ®Google Scholar
• Akiyoshi K, Deguchi S, Moriguchi N, Yamaguchi S, Sunamoto J. 1993. Self-aggregates of hydrophobized polysaccharides in water. Formation and characteristics of nanoparticles. Macromolecules 26: 3062–3068
   Web of Science ®Google Scholar
• Anto Shering M, Kannan C, Sabari Kumar K, Sathish Kumar V, Suganeshwari M. 2011. Formulation of 5-fluorouracil loaded chitosan nanoparticles by emulsion droplet coalescence method for cancer therapy. Int J Pharm Bio Arc 2, 926–931
   Google Scholar
• Bajaj IB; Singhal RS. 2010. Effect of aeration and agitation on synthesis of poly (γ-glutamic acid) in batch cultures of Bacillus licheniformis NCIM 2324. Biotechnology and Bioprocess Engineering 15, 635–640
   Google Scholar
• Bajpai AK, Choubey J. 2006. Design of gelatin nanoparticles as swelling controlled delivery system for chloroquine phosphate. J Mater Sci Mater Med 17: 345–358
   PubMed Web of Science ®Google Scholar
• Barratt GM. 2000. Therapeutic applications of colloidal drug carriers. Pharm Sci Technol Today 3: 163–171
   PubMedGoogle Scholar
• Bodmeier R, Oh K, Pramar Y. 1989. Preparation and evaluation of drug-containing chitosan beads. Drug Dev Ind Pharm 15: 1475–1494
   Web of Science ®Google Scholar
• Bokharaei M, Margaritis A, Xenocostas A, Freeman DJ. 2011. Erythropoietin encapsulation in chitosan nanoparticles and kinetics of drug release. Curr Drug Deliv 8: 164–171
   PubMedGoogle Scholar
• Bulmer C, Margaritis A, Xenocostas A. 2012a. Production and characterization of novel chitosan nanoparticles for controlled release of rHu-erythropoietin. Biochem Eng J 68: 61–69
   Web of Science ®Google Scholar
• Bulmer C, Margaritis A, Xenocostas A. 2012b. Encapsulation and controlled release of recombinant human erythropoietin from chitosan-carrageenan nanoparticles. Curr Drug Deliv 9: 527–537
   PubMed Web of Science ®Google Scholar
• Calvo P, Remuñán-López C, Vila-Jato JL, Alonso MJ. 1997. Novel hydrophilic chitosan-polyethylene oxide nanoparticles as protein carriers. J Appl Poly Sci 63: 125–132
   Web of Science ®Google Scholar
• Calvo P, Vila-Jato JL, Alonso MJ. 1997. Evaluation of cationic polymer-coated nanocapsules as ocular drug carriers. Int J Pharm 153: 41–50
   Web of Science ®Google Scholar
• Carter DC, He XM, Munson SH, Twigg PD, Gernert KM, Broom MB, Miller TY. 1989. Three-dimensional structure of human serum albumin. Science 244: 1195–1198
   PubMed Web of Science ®Google Scholar
• Cascone MG, Lazzeri L, Carmignani C, Zhu Z. 2002. Gelatin nanoparticles produced by a simple W/O emulsion as delivery system for methotrexate. J Mater Sci Mater Med 13: 523–526
   PubMed Web of Science ®Google Scholar
• Chakravarthi SS, Robinson DH. 2008. Biodegradable nanoparticles. In: Gads SC, ed. Pharmaceutical Manufacturing Handbook. Haboken: John Wiley & Sons, 535–565
   Google Scholar
• Chen M, Liu L, Liu Y, Yang W, Li X, Li R, Zhou Z, Wang Y, Zhang Q. 2011. Preparation and characterization of self-assembled nanoparticles of 6- O-cholesterol-modified chitosan for drug delivery. Carbohydr Polym 84: 1244–1251
   Web of Science ®Google Scholar
• Cheng KC, Demirci A, Catchmark JM. 2011. Pullulan: biosynthesis, production, and applications. Appl Microbiol Biotechnol 92: 29–44
   PubMed Web of Science ®Google Scholar
• Cho CS, Jeong YI, Ishihara T, Takei R, Park JU, Park KH, Maruyama A, Akaike T. 1997. Simple preparation of nanoparticles coated with carbohydrate-carrying polymers. Biomaterials 18: 323–326
   PubMed Web of Science ®Google Scholar
• Cho CS, Kobayashi A, Takei R, Ishihara T, Maruyama A, Akaike T. 2001. Receptor-mediated cell modulator delivery to hepatocyte using nanoparticles coated with carbohydrate-carrying polymers. Biomaterials 22: 45–51
   PubMed Web of Science ®Google Scholar
• Chuang C, Don T, Chiu W. 2009. Synthesis of chitosan-based thermo- and pH-responsive porous nanoparticles by temperature-dependent self-assembly method and their application in drug release. J Polym Sci Part A: Polym Chem 47: 5126–5136
   Web of Science ®Google Scholar
• Coester CJ, Langer K, van Briesen H, Kreuter J. 2000. Gelatin nanoparticles by two step desolvation–a new preparation method, surface modifications and cell uptake. J Microencapsul 17: 187–193
   PubMed Web of Science ®Google Scholar
• Cohn EJ, Strong LE. 1946. Preparation and properties of serum and plasma proteins; a system for the separation into fractions of the protein and lipoprotein components of biological tissues and fluids. J Am Chem Soc 68: 459–475
   PubMed Web of Science ®Google Scholar
• Courts A. 1954. The N-terminal amino acid residues of gelatin. 1. Intact gelatins. Biochem J 58: 70–74
   PubMedGoogle Scholar
• Cromwick AM, Birrer GA, Gross RA. 1996. Effects of pH and aeration on γ-poly(glutamic acid) formation by Bacillus licheniformis in controlled batch fermentor cultures. Biotechnol Bioeng 50: 222–227
   PubMed Web of Science ®Google Scholar
• Daly M, Knorr D. 1988. Chitosan-alginate complex coacervate capsules: effects of calcium chloride, plasticizers, and polyelectrolytes on mechanical stability. Biotechnol Progr 4: 76–81
   Web of Science ®Google Scholar
• De Jong WH, Borm PJ. 2008. Drug delivery and nanoparticles:applications and hazards. Int J Nanomedicine 3: 133–149
   PubMed Web of Science ®Google Scholar
• Duclairoir C, Nakache E, Marchais H, Orecchioni A. (1998). Formation of gliadin nanoparticles: Influence of the solubility parameter of the protein solvent. Colloid Polym Sci 276: 321–327
   Web of Science ®Google Scholar
• Duclairoir C, Orecchioni AM, Depraetere P, Osterstock F, Nakache E. 2003. Evaluation of gliadins nanoparticles as drug delivery systems: a study of three different drugs. Int J Pharm 253: 133–144
   PubMed Web of Science ®Google Scholar
• El-Shabouri MH. 2002. Positively charged nanoparticles for improving the oral bioavailability of cyclosporin-A. Int J Pharm 249: 101–108
   PubMed Web of Science ®Google Scholar
• Elzoghby AO, Samy WM, Elgindy NA. 2012. Albumin-based nanoparticles as potential controlled release drug delivery systems. J Control Release 157: 168–182
   PubMed Web of Science ®Google Scholar
• Ezpeleta I, Irache JM, Stainmesse S, Chabenat C, Gueguen J, Popineau Y, Orecchioni A. (1996). Gliadin nanoparticles for the controlled release of all-trans-retinoic acid. Int J Pharm 131: 191–200
   Web of Science ®Google Scholar
• Fakirov S. 2007. Gelatin and gelatin-based biodegradable composites: manufacturing, properties, and biodegradation behavior. In: Fakirov S, Bhattacharyya D, eds. Handbook of Engineering Biopolymers: Homopolymers, Blends, and Composites. Munich: Hanser, 419–464
   Google Scholar
• Farrugia CA, Groves MJ. 1999. Gelatin behaviour in dilute aqueous solution: designing a nanoparticulate formulation. J Pharm Pharmacol 51: 643–649
   PubMed Web of Science ®Google Scholar
• Gaur U, Sahoo SK, De TK, Ghosh PC, Maitra A, Ghosh PK. 2000. Biodistribution of fluoresceinated dextran using novel nanoparticles evading reticuloendothelial system. Int J Pharm 202: 1–10
   PubMed Web of Science ®Google Scholar
• Gianibelli MC, Larroque OR, MacRitchie F, Wrigley CW. (2001a). Biochemical, genetic, and molecular characterization of wheat glutenin and its component subunits. Cereal Chem 78, 635–646
   Web of Science ®Google Scholar
• Gianibelli MC, Larroque OR, Macritchie F, Wrigley CW. (2001b). Biochemical, genetic, and molecular characterization of wheat endosperm proteins. Cereal Chem 78, 635–646
   Web of Science ®Google Scholar
• Goncalves VL, Laranjeira MCM, Fávere VT, Pedrosa RC. (2005). Effect of crosslinking agents on chitosan microspheres in controlled release of diclofenac sodium. Polímeros 15: 6–12
   Google Scholar
• Gupta M, Gupta AK. 2004a. Hydrogel pullulan nanoparticles encapsulating pBUDLacZ plasmid as an efficient gene delivery carrier. J Control Release 99: 157–166
   PubMed Web of Science ®Google Scholar
• Gupta M, Gupta AK. 2004b. In vitro cytotoxicity studies of hydrogel pullulan nanoparticles prepared by AOT/N-hexane micellar system. J Pharm Pharm Sci 7: 38–46
   PubMed Web of Science ®Google Scholar
• Haug A. 1964. Composition and properties of alginates. Composition and properties of alginates (Thesis). Trondheim: Norwegian Institute of Technology
   Google Scholar
• Heinze T, Liebert T, Heublein B, Hornig S. 2006. Functional polymers based on dextran. Berlin: Springer
   Google Scholar
• Higashi N, Shosu T, Koga T, Niwa M, Tanigawa T. 2006. pH-responsive, self-assembling nanoparticle from a fullerene-tagged poly(L-glutamic acid) and its superoxide dismutase mimetic property. J Colloid Interface Sci 298: 118–123
   PubMed Web of Science ®Google Scholar
• Hitzman CJ, Wattenberg LW, Wiedmann TS. 2006. Pharmacokinetics of 5-fluorouracil in the hamster following inhalation delivery of lipid-coated nanoparticles. J Pharm Sci 95: 1196–1211
   PubMed Web of Science ®Google Scholar
• Hu Y, Jiang X, Ding Y, Ge H, Yuan Y, Yang C. 2002. Synthesis and characterization of chitosan-poly(acrylic acid) nanoparticles. Biomaterials 23: 3193–3201
   PubMed Web of Science ®Google Scholar
• Ibrahim NK, Desai N, Legha S, Soon-Shiong P, Theriault RL, Rivera E, Esmaeli B, Ring SE, Bedikian A, Hortobagyi GN, Ellerhorst JA. 2002. Phase I and pharmacokinetic study of ABI-007, a Cremophor-free, protein-stabilized, nanoparticle formulation of paclitaxel. Clin Cancer Res 8: 1038–1044
   PubMed Web of Science ®Google Scholar
• Jeong YI, Seo SJ, Park IK, Lee HC, Kang IC, Akaike T, Cho CS. 2005. Cellular recognition of paclitaxel-loaded polymeric nanoparticles composed of poly(γ-benzyl L-glutamate) and poly(ethylene glycol) diblock copolymer endcapped with galactose moiety. Int J Pharm 296: 151–161
   PubMed Web of Science ®Google Scholar
• Jones RT. 2004. Gelatin: Manufacture and physio-chemical properties. In: Podczeck F, Jones B, eds. Pharmaceutical Capsules. London: Pharmaceutical Press, 23–39
   Google Scholar
• Karthikeyan RS, Rakshit SK, Baradarajan A. 1996. Optimization of batch fermentation conditions for dextran production. Biopro Eng 15: 247–251
   Google Scholar
• Kim IS, Oh IJ. 2010. Preparation and characterization of stearic acid-pullulan nanoparticles. Arch Pharm Res 33: 761–767
   PubMed Web of Science ®Google Scholar
• Koizumi F, Kitagawa M, Negishi T, Onda T, Matsumoto S, Hamaguchi T, Matsumura Y. 2006. Novel SN-38-incorporating polymeric micelles, NK012, eradicate vascular endothelial growth factor-secreting bulky tumors. Cancer Res 66: 10048–10056
   PubMed Web of Science ®Google Scholar
• Kratz F. 2008. Albumin as a drug carrier: design of prodrugs, drug conjugates and nanoparticles. J Control Release 132: 171–183
   PubMed Web of Science ®Google Scholar
• Krause HJ, Rohdewald P. 1985. Preparation of gelatin nanocapsules and their pharmaceutical characterization. Pharm Res 2: 239–243
   PubMedGoogle Scholar
• Kumari A, Yadav SK, Yadav SC. 2010. Biodegradable polymeric nanoparticles based drug delivery systems. Colloids Surf B Biointerfaces 75: 1–18
   PubMed Web of Science ®Google Scholar
• Kuriyel R, Fushijima M, Jung GW. 2009. Advancements in membrane processes for pharmaceutical applications. In: Pabby AK, Rizvi SS, Sastre AM, eds. Handbook of Membrane Separations: Chemical, Pharmaceutical, Food and Biotechnological Applications. Boca Raton: CRC Press, 415–424
   Google Scholar
• Langer K, Balthasar S, Vogel V, Dinauer N, von Briesen H, Schubert D. 2003. Optimization of the preparation process for human serum albumin (HSA) nanoparticles. Int J Pharm 257: 169–180
   PubMed Web of Science ®Google Scholar
• Leathers TD. 2005. Dextran. In: Steinbüchel A, ed. Polysaccharides and polyamides in the food industry: properties, production, and patents volume 1. Weinheim: Wiley-VCH, 233–257
   Google Scholar
• Lee KY, Mooney DJ. 2012. Alginate: properties and biomedical applications. Prog Polym Sci 37: 106–126
   PubMed Web of Science ®Google Scholar
• Leong YS, Candau F. 1982. Inverse microemulsion polymerization. J Phys Chem 86: 2269–2271
   Web of Science ®Google Scholar
• Leong KW, Mao HQ, Truong-Le VL, Roy K, Walsh SM, August JT. 1998. DNA-polycation nanospheres as non-viral gene delivery vehicles. J Control Release 53: 183–193
   PubMed Web of Science ®Google Scholar
• Li JK, Wang N, Wu XS. 1998. Gelatin nanoencapsulation of protein/peptide drugs using an emulsifier-free emulsion method. J Microencapsul 15: 163–172
   PubMed Web of Science ®Google Scholar
• Lin W, Coombes AG, Davies MC, Davis SS, Illum L. 1993. Preparation of sub-100 nm human serum albumin nanospheres using a pH-coacervation method. J Drug Target 1: 237–243
   PubMed Web of Science ®Google Scholar
• Lin W, Coombes AG, Garnett MC, Davies MC, Schacht E, Davis SS, Illum L. 1994. Preparation of sterically stabilized human serum albumin nanospheres using a novel Dextranox-MPEG crosslinking agent. Pharm Res 11: 1588–1592
   PubMed Web of Science ®Google Scholar
• Lin W, Garnett MC, Davies MC, Bignotti F, Ferruti P, Davis SS, Illum L. 1997. Preparation of surface-modified albumin nanospheres. Biomaterials 18: 559–565
   PubMed Web of Science ®Google Scholar
• Liu Z, Jiao Y, Wang Y, Zhou C, Zhang Z. 2008. Polysaccharides-based nanoparticles as drug delivery systems. Adv Drug Deliv Rev 60: 1650–1662
   PubMed Web of Science ®Google Scholar
• Lochke AH, Rale VB. 1995. Trends in microbial production of pullulan and its novel applications in the food industry. In: Hui YH, Khachatourians GG, eds. Food Biotechnology: Microorganisms. New Jersey: Wiley-IEEE, 589–609
   Google Scholar
• López-León T, Carvalho EL, Seijo B, Ortega-Vinuesa JL, Bastos-González D. 2005. Physicochemical characterization of chitosan nanoparticles: electrokinetic and stability behavior. J Colloid Interface Sci 283: 344–351
   PubMed Web of Science ®Google Scholar
• Maitra AN, Ghosh PK, De TK, Sahoo S. 1999. Process for the preparation of highly monodisperse polymeric hydrophilic nanoparticles. US Patent No. 587411
   Google Scholar
• Manocha B, Margaritis A. 2008. Production and characterization of γ-polyglutamic acid nanoparticles for controlled anticancer drug release. Crit Rev Biotechnol 28: 83–99
   PubMed Web of Science ®Google Scholar
• Marty JJ, Oppenheim RC, Speiser P. 1978. Nanoparticles–a new colloidal drug delivery system. Pharm Acta Helv 53: 17–23
   PubMedGoogle Scholar
• Masotti A, Ortaggi G. 2009. Chitosan micro- and nanospheres: fabrication and applications for drug and DNA delivery. Mini Rev Med Chem 9: 463–469
   PubMed Web of Science ®Google Scholar
• Matejtschuk P, Dash CH, Gascoigne EW. 2000. Production of human albumin solution: a continually developing colloid. Br J Anaesth 85: 887–895
   PubMed Web of Science ®Google Scholar
• Mehravar R, Jahanshahi M, Saghatoleslami N. (2009). Fabrication and evaluation of human serum albumin (HSA) nanoparticles for drug delivery application. Int J Nanosci 8, 319–322
   Google Scholar
• Mishra V, Mahor S, Rawat A, Gupta PN, Dubey P, Khatri K, Vyas SP. 2006. Targeted brain delivery of AZT via transferrin anchored pegylated albumin nanoparticles. J Drug Target 14: 45–53
   PubMed Web of Science ®Google Scholar
• Mitra S, Gaur U, Ghosh PC, Maitra AN. 2001. Tumour targeted delivery of encapsulated dextran-doxorubicin conjugate using chitosan nanoparticles as carrier. J Control Release 74: 317–323
   PubMed Web of Science ®Google Scholar
• Motwani SK, Chopra S, Talegaonkar S, Kohli K, Ahmad FJ, Khar RK. 2008. Chitosan-sodium alginate nanoparticles as submicroscopic reservoirs for ocular delivery: formulation, optimisation and in vitro characterisation. Eur J Pharm Biopharm 68: 513–525
   PubMed Web of Science ®Google Scholar
• Munshi N, Chakarvorty K, De TK, Maitra AN. 1995. Activity and stability studies of ultrafine nanoencapsulated catalase and penicillinase. Colloid Polym Sci 273: 464–472
   Google Scholar
• Na K, Bae YH. 2002. Self-assembled hydrogel nanoparticles responsive to tumor extracellular pH from pullulan derivative/sulfonamide conjugate: characterization, aggregation, and adriamycin release in vitro. Pharm Res 19: 681–688
   PubMed Web of Science ®Google Scholar
• Na K, Lee ES, Bae YH. 2003. Adriamycin loaded pullulan acetate/sulfonamide conjugate nanoparticles responding to tumor pH: pH-dependent cell interaction, internalization and cytotoxicity in vitro. J Control Release 87: 3–13
   PubMed Web of Science ®Google Scholar
• Niwa T, Takeuchi H, Hino T, Kunou N, Kawashima Y. 1993. Preparations of biodegradable nanospheres of water-soluble and insoluble drugs with D,L-lactide/glycolide copolymer by a novel spontaneous emulsification solvent diffusion method, and the drug release behavior. J Control Release 25: 89–98
   Web of Science ®Google Scholar
• Nouvel C, Raynaud J, Marie E, Dellacherie E, Six JL, Durand A. 2009. Biodegradable nanoparticles made from polylactide-grafted dextran copolymers. J Colloid Interface Sci 330: 337–343
   PubMedGoogle Scholar
• Nussinovitch A. 1997. Hydrocolloid applications: gum technology in the food and other industries. London: Blackie Academic & Professional
   Google Scholar
• Oppenheim RC, Marty JJ, Speiser P. (1978). Injectable compositions, nanoparticles useful therein and process of manufacturing same. US Patent 4107288
   Google Scholar
• Oppenheim RC, Stewart NF. (1979). The manufacture and tumour cell uptake of nanoparticles labelled with fluorescein isothiocyanate. Drug Dev Ind Pharm 5: 563–571
   Google Scholar
• Patil GV. 2003. Biopolymer albumin for diagnosis and in drug delivery. Drug Develop Res 58: 219–247
   Google Scholar
• Peniche H, Peniche C. 2011. Chitosan nanoparticles: a contribution to nanomedicine. Polym Int 60: 883–889
   Google Scholar
• Poncelet D. 2001. Production of alginate beads by emulsification/internal gelation. Ann NY Acad Sci 944: 74–82
   PubMed Web of Science ®Google Scholar
• Quong D, Neufeld RJ, Skjåk-Braek G, Poncelet D. 1998. External versus internal source of calcium during the gelation of alginate beads for DNA encapsulation. Biotechnol Bioeng 57: 438–446
   PubMed Web of Science ®Google Scholar
• Pinto Reis C, Neufeld RJ, Ribeiro AJ, Veiga F. 2006. Nanoencapsulation I. Methods for preparation of drug-loaded polymeric nanoparticles. Nanomedicine 2: 8–21
   PubMed Web of Science ®Google Scholar
• Reis CP, Neufeld RJ, Vilela S, Ribeiro AJ, Veiga F. 2006. Review and current status of emulsion/dispersion technology using an internal gelation process for the design of alginate particles. J Microencapsul 23: 245–257
   PubMed Web of Science ®Google Scholar
• Richard A, Margaritis A. 2001. Poly(glutamic acid) for biomedical applications. Crit Rev Biotechnol 21: 219–232
   PubMed Web of Science ®Google Scholar
• Sæther HV, Holme HK, Maurstad G, Smidsrød O, Stokke BT. 2008. Polyelectrolyte complex formation using alginate and chitosan. Carbohydr Polym 74: 813–821
   Web of Science ®Google Scholar
• Sarmento B, Ferreira D, Veiga F, Ribeiro A. 2006. Characterization of insulin-loaded alginate nanoparticles produced by ionotropic pre-gelation through DSC and FTIR studies. Carbohydr Polym 66: 1–7
   Web of Science ®Google Scholar
• Sarmento B, Ribeiro A, Veiga F, Sampaio P, Neufeld R, Ferreira D. 2007. Alginate/chitosan nanoparticles are effective for oral insulin delivery. Pharm Res 24: 2198–2206
   PubMed Web of Science ®Google Scholar
• Singh R, Lillard JW Jr. 2009. Nanoparticle-based targeted drug delivery. Exp Mol Pathol 86: 215–223
   PubMed Web of Science ®Google Scholar
• Sivabalan M, Anto Shering M, Reddy P, Vasudevaiah AJ, Nigila G. 2011. Formulation and evaluation of 5-fluoruracil loaded chitosan and eudragit nanoparticles for cancer therapy. Pharmacie Globa: Int J Compr Pharm 2: 1–4
   PubMedGoogle Scholar
• Stinchcombe TE. 2007. Nanoparticle albumin-bound paclitaxel: a novel Cremphor-EL-free formulation of paclitaxel. Nanomedicine (Lond) 2: 415–423
   PubMed Web of Science ®Google Scholar
• Sundar S, Kundu J, Kundu SC. 2010. Biopolymeric nanoparticles Sci Tech Adv Mat 11: 014104
   Google Scholar
• Synowiecki J, Al-Khateeb NA. 2003. Production, properties, and some new applications of chitin and its derivatives. Crit Rev Food Sci Nutr 43: 145–171
   PubMed Web of Science ®Google Scholar
• Tabata Y, Ikada Y. 1989. Synthesis of gelatin microspheres containing interferon. Pharm Res 6: 422–427
   PubMed Web of Science ®Google Scholar
• Tahara K, Yamamoto H, Takeuchi H, Kawashima Y. 2007. Development of gene delivery system using PLGA nanospheres. Yakugaku Zasshi 127: 1541–1548
   PubMedGoogle Scholar
• Tang M, Dou H, Sun K. 2006. One-step synthesis of dextran-based stable nanoparticles assisted by self-assembly. Polymer 47: 728–734
   Web of Science ®Google Scholar
• Tang ES, Huang M, Lim LY. 2003. Ultrasonication of chitosan and chitosan nanoparticles. Int J Pharm 265: 103–114
   PubMed Web of Science ®Google Scholar
• Thewissen BG, Celus I, Brijs K, Delcour JA. 2011. Foaming properties of wheat gliadin. J Agric Food Chem 59: 1370–1375
   PubMed Web of Science ®Google Scholar
• Tiyaboonchai W, Woiszwillo J, Middaugh CR. 2001. Formulation and characterization of amphotericin B-polyethylenimine-dextran sulfate nanoparticles. J Pharm Sci 90: 902–914
   PubMed Web of Science ®Google Scholar
• Tiyaboonchai W, Woiszwillo J, Sims RC, Middaugh CR. 2003. Insulin containing polyethylenimine-dextran sulfate nanoparticles. Int J Pharm 255: 139–151
   PubMed Web of Science ®Google Scholar
• Tokumitsu H, Ichikawa H, Fukumori Y. 1999a. Chitosan-gadopentetic acid complex nanoparticles for gadolinium neutron-capture therapy of cancer: preparation by novel emulsion-droplet coalescence technique and characterization. Pharm Res 16: 1830–1835
   PubMed Web of Science ®Google Scholar
• Tokumitsu H, Ichikawa H, Fukumori Y, Block LH. 1999b. Preparation of gadopentetic acid-loaded chitosan microparticles for gadolinium neutron-capture therapy of cancer by a novel emulsion-droplet coalescence technique. Chem Pharm Bull 47: 838–842
   PubMed Web of Science ®Google Scholar
• Toshio Y, Mitsuru H, Shozo M, Hitoshi S. 1981. Specific delivery of mitomycin c to the liver, spleen and lung: Nano- and microspherical carriers of gelatin. Int J Pharm 8: 131–141
   Google Scholar
• Totre J, Ickowicz D, Domb A. 2011. Properties and hemostratic application of gelation. In: Domb A, Kumar N, Ezra A, eds. Biodegradable Polymers in Clinical Use and Clinical Development. Hoboken: John Wiley and Sons Inc., 92–106
   Google Scholar
• Tsai ML, Bai SW, Chen RH. 2008. Cavitation effects versus stretch effects resulted in different size and polydispersity of ionotropic gelation chitosan–sodium tripolyphosphate nanoparticle. Carbohydr Polym 71: 448–457
   Web of Science ®Google Scholar
• Vauchel P, Le Roux K, Leroux K, Kaas R, Arhaliass A, Baron R, Legrand J. 2009. Kinetics modeling of alginate alkaline extraction from Laminaria digitata. Bioresour Technol 100: 1291–1296
   PubMed Web of Science ®Google Scholar
• Villemson AL, Couvreur P, Gref R, Larionova NI. 2007. Amphiphilic derivatives of dextran and related nanoparticles. Polym Sci Ser A 49: 708–715
   Google Scholar
• Wang Y, Liu L, Jiang Q, Zhang Q. 2007. Self-aggregated nanoparticles of cholesterol-modified chitosan conjugate as a novel carrier of epirubicin. Eur Polym J 43: 43–51
   Web of Science ®Google Scholar
• Weber C, Kreuter J, Langer K. 2000. Desolvation process and surface characteristics of HSA-nanoparticles. Int J Pharm 196: 197–200
   PubMed Web of Science ®Google Scholar
• Xu R, Fisher M, Juliano RL. 2011. Targeted albumin-based nanoparticles for delivery of amphipathic drugs. Bioconjug Chem 22: 870–878
   PubMed Web of Science ®Google Scholar
• Yang L, Cui F, Cun D, Tao A, Shi K, Lin W. 2007. Preparation, characterization and biodistribution of the lactone form of 10-hydroxycamptothecin (HCPT)-loaded bovine serum albumin (BSA) nanoparticles. Int J Pharm 340: 163–172
   PubMed Web of Science ®Google Scholar
• Yeh MK, Cheng KM, Hu CS, Huang YC, Young JJ. 2011. Novel protein-loaded chondroitin sulfate-chitosan nanoparticles: preparation and characterization. Acta Biomater 7: 3804–3812
   PubMed Web of Science ®Google Scholar
• Yoshioka T, Hashida M, Muranishi S, Sezaki H. 1981. Specific delivery of mitomycin C to the liver, spleen and lung: nano- and microspherical carriers of gelatin. Int J Pharm 81: 131–141
   Google Scholar
• You JO, Liu YC, Peng CA. 2006. Efficient gene transfection using chitosan-alginate core-shell nanoparticles. Int J Nanomed 1: 173–180
   PubMed Web of Science ®Google Scholar
• You J, Peng C. 2005. Calcium-alginate nanoparticles formed by reverse microemulsion as gene carriers. Macromol Symp 219: 147–153
   Google Scholar
• Yuan X, Yuan Y, Li H. 2006. Preparation of cholesterol-modified chitosan self-aggregated nanoparticles for delivery of drugs to ocular surface. Carbohydr Polym 65: 337–345
   Web of Science ®Google Scholar
• Zhang HZ, Li XM, Gao FP, Liu LR, Zhou ZM, Zhang QQ. 2010. Preparation of folate-modified pullulan acetate nanoparticles for tumor-targeted drug delivery. Drug Deliv 17: 48–57
   PubMed Web of Science ®Google Scholar